An epidemiological study of neovascular age-related macular degeneration in Germany

被引:11
作者
Krause, Lothar [1 ]
Yousif, Tarik
Pohl, Karin [2 ]
机构
[1] Municipal Hosp Dessau, D-06847 Dessau, Germany
[2] Novartis Pharma GmbH, Nurnberg, Germany
关键词
AMD diagnosis; AMD epidemiology; AMD treatment; Neovascular age-related macular degeneration; Optical coherence tomography; BLUE MOUNTAINS EYE; INTRAVITREAL RANIBIZUMAB LUCENTIS; VISUAL IMPAIRMENT; RISK-FACTORS; PREVALENCE; MACULOPATHY; TRIAL; OLDER; POPULATION; ANCHOR;
D O I
10.1185/03007995.2013.832184
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Neovascular or wet age-related macular degeneration (AMD) is one of the leading causes of blindness in industrialized countries; however, there is a lack of recent epidemiological data from Germany. The aim of this study was to collect epidemiological data from patients in Germany with suspected neovascular AMD and evaluate the diagnostic procedures performed and treatments used at clinics. Methods: This was a Germany-based, multicentre, retrospective review of data from patients with suspected neovascular AMD visiting ophthalmology clinics over an 18 month period in 2008-10. Clinical characteristics, functional symptoms and examination results were recorded. In addition, ophthalmologists completed a questionnaire on neovascular AMD diagnosis and treatment. Results: Ten sites collected data from 2498 patients (64.0% female) with a mean decimal visual acuity of 0.4 +/- 0.3 at the time of diagnosis of neovascular AMD. The mean age at the time of diagnosis was 76.9 +/- 8.9 years for patients with the right eye affected and 77.0 +/- 8.3 years for patients with the left eye affected. The most frequent pathological findings detected by routine ophthalmic examination were old lesions (31.2%), intra/subretinal fluid (18.1%), new lesions (13.0%), and intra/subretinal haemorrhage (11.4%). A confirmed diagnosis of neovascular AMD was most frequently based on fundoscopy (67.3%), fluorescein angiography (39.6%), and biomicroscopy (35.7%) tests but rarely on optical coherence tomography (8.9%). The most frequently documented comorbidity with neovascular AMD was hypertension and other cardiovascular diseases (57.5%). Seven ophthalmologists completed the questionnaire with the majority of ophthalmologists agreeing that regular ophthalmic examination can prevent the development of late-stage neovascular AMD. Conclusion: Neovascular AMD is a frequent diagnosis in German ophthalmology clinics. As visual acuity is already poor in most patients with suspected neovascular AMD, regular preventive ophthalmologic examinations should be considered in high risk patients. Study limitations: Limitations of the study include the lack of a comparator cohort, which limited the amount of analyses that could be performed. Additionally, a study eye was not defined and information was collected separately for each affected eye and therefore analysed separately. Furthermore, a small number of ophthalmologists completed the questionnaire, limiting the objectivity.
引用
收藏
页码:1391 / 1397
页数:7
相关论文
共 24 条
[1]  
Anand R, 2000, OPHTHALMOLOGY, V107, P2224
[2]   Vision-Related Function after Ranibizumab Treatment by Better- or Worse-Seeing Eye Clinical Trial Results from MARINA and ANCHOR [J].
Bressler, Neil M. ;
Chang, Tom S. ;
Suner, Ivan J. ;
Fine, Jennifer T. ;
Dolan, Chantal M. ;
Ward, James ;
Ianchulev, Tsontcho .
OPHTHALMOLOGY, 2010, 117 (04) :747-U124
[3]   Ranibizumab versus verteporfin for neovascular age-related macular degeneration [J].
Brown, David M. ;
Kaiser, Peter K. ;
Michels, Mark ;
Soubrane, Gisele ;
Heier, Jeffrey S. ;
Kim, Robert Y. ;
Sy, Judy P. ;
Schneider, Susan .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14) :1432-1444
[4]   Optical coherence tomography features of acute central serous chorioretinopathy versus neovascular age-related macular degeneration [J].
Cho, Minhee ;
Athanikar, Aditya ;
Paccione, Jeffrey ;
Wald, Kenneth J. .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2010, 94 (05) :597-599
[5]  
Current opinion of the German Ophthalmological Society and the Retina Society the Professional Association of German Ophthalmologists, 2012, CURRENT OPINION GERM
[6]   Optical coherence tomography-based intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration [J].
Ernst B.J. ;
Barkmeier A.J. ;
Akduman L. .
International Ophthalmology, 2010, 30 (3) :267-270
[7]   Causes of visual impairment in people aged 75 years and older in Britain: an add-on study to the MRC Trial of Assessment and Management of Older People in the Community [J].
Evans, JR ;
Fletcher, AE ;
Wormald, RPL .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2004, 88 (03) :365-370
[8]   Risk factors for age-related macular degeneration [J].
Evans, JR .
PROGRESS IN RETINAL AND EYE RESEARCH, 2001, 20 (02) :227-253
[9]   An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (lucentis) for neovascular age-related macular degeneration [J].
Fung, Anne E. ;
Lalwani, Geeta A. ;
Rosenfeld, Philip J. ;
Dubovy, Sander R. ;
Michels, Stephan ;
Feuer, William J. ;
Puliafito, Carmen A. ;
Davis, Janet L. ;
Flynn, Harry W., Jr. ;
Esquiabro, Maria .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2007, 143 (04) :566-583
[10]  
Hawkins BS, 1999, MOL VIS, V5